Explore more publications!
Idaho Healthcare Hub
Got News to Share?

Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 28, 2025

Global Cardiovascular Devices Market to Reach USD 110.39 Billion by 2029 | MarketsandMarkets™
November 28, 2025

Global Cardiovascular Devices Market to Reach USD 110.39 Billion by 2029 | MarketsandMarkets™

Indeterminate GlobeNewswire
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
November 28, 2025

Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock

Indeterminate GlobeNewswire
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 28, 2025

NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 28, 2025

PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Boehringer Ingelheim announces appointment to Board of Managing Directors
November 28, 2025

Boehringer Ingelheim announces appointment to Board of Managing Directors

Indeterminate GlobeNewswire
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 28, 2025

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Hydreight Technologies Acquires 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase up to 40%, and Establishes Strategic Partnership
November 28, 2025

Hydreight Technologies Acquires 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase up to 40%, and Establishes Strategic Partnership

Indeterminate GlobeNewswire
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
November 28, 2025

Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings

Indeterminate GlobeNewswire
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
November 28, 2025

TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference

Indeterminate GlobeNewswire
Kane Biotech Announces Third Quarter 2025 Financial Results
November 28, 2025

Kane Biotech Announces Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
L’Agence des médicaments du Canada émet une recommandation positive pour le remboursement de SKYRIZI® (risankizumab) pour le traitement de la colite ulcéreuse, et AbbVie conclut une lettre d’intention avec l’Alliance pharmaceutique pancanadienne
November 28, 2025

L’Agence des médicaments du Canada émet une recommandation positive pour le remboursement de SKYRIZI® (risankizumab) pour le traitement de la colite ulcéreuse, et AbbVie conclut une lettre d’intention avec l’Alliance pharmaceutique pancanadienne

Indeterminate GlobeNewswire
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance
November 28, 2025

SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance

Indeterminate GlobeNewswire
Shriners Hospitals for Children Canada and Children’s Hospital at LHSC launch landmark research program to advance care in rare childhood bone disorders
November 28, 2025

Shriners Hospitals for Children Canada and Children’s Hospital at LHSC launch landmark research program to advance care in rare childhood bone disorders

Indeterminate GlobeNewswire
Les Hôpitaux Shriners pour enfants Canada et l’Hôpital pour enfants du Centre des sciences de la santé de London lancent un programme de recherche historique pour faire progresser les soins liés aux maladies osseuses rares chez l’enfant
November 28, 2025

Les Hôpitaux Shriners pour enfants Canada et l’Hôpital pour enfants du Centre des sciences de la santé de London lancent un programme de recherche historique pour faire progresser les soins liés aux maladies osseuses rares chez l’enfant

Indeterminate GlobeNewswire
Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025
November 28, 2025

Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025

Indeterminate GlobeNewswire
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 27 novembre 2025
November 28, 2025

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 27 novembre 2025

Indeterminate GlobeNewswire
InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis
November 28, 2025

InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis

Indeterminate GlobeNewswire
Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan
November 28, 2025

Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions